{"id":350345,"date":"2024-10-20T00:41:49","date_gmt":"2024-10-20T00:41:49","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-172692019\/"},"modified":"2024-10-26T00:28:07","modified_gmt":"2024-10-26T00:28:07","slug":"bs-en-172692019","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-172692019\/","title":{"rendered":"BS EN 17269:2019"},"content":{"rendered":"
This document defines the core data set for a patient summary document that supports continuity of care for a person and coordination of healthcare. It is specifically aimed at supporting the use case scenario for \u2018unplanned, cross border care\u2019 and is intended to be an international patient summary (IPS). The data set is minimal and non-exhaustive, providing a robust, well-defined core set of data items. This tight focus on the use case enables the IPS to also be used in planned care, and for both unplanned and planned care to be supported by this data set within local and national contexts, thereby increasing its utility and value.<\/p>\n
It uses the European Guideline from the eHN as the initial source for the patient summary requirements but takes into consideration other international efforts so as to provide an interoperable data set specification for global application.<\/p>\n
This IPS standard provides an abstract definition of a Patient Summary from which derived models are implementable. Due to its nature therefore, readers should be aware that the compliance with this standard doesn\u2019t imply automatic technical interoperability; this result, enabled by this standard, can be reached with the conformity to standards indicated in the associated technical specification and implementation guides.<\/p>\n
This international standard does not cover workflow processes of data entry, data collection, the summarization act itself, nor subsequent data presentation, nor assimilation, nor aggregation.<\/p>\n
It is not an implementation guide that is concerned with the various technical layers beneath the application layer. Implementation guidance for specifically jurisdictional concerns, e.g. Directives, terminologies, formats etc., is specified in the associated Technical Specification ( CEN\/TS 17288<\/span><\/span>).<\/p>\n In particular, representation by various coding schemes, additional structures and terminologies are not part of this standard. Terminology and its binding are addressed in the associated Technical Specification ( CEN\/TS 17288<\/span><\/span>). The Identification of Medicinal Products standards (abbreviated to IDMP) are the recommended target for the Medication Summary related to this standard but, prior to IDMP\u2019s full implementation in practice, this IPS standard cannot insist in its use at this point in time and recognizes that interim schemes may be necessary until IDMP becomes established as a norm.<\/p>\n Health informatics. The International Patient Summary<\/b><\/p>\nPDF Catalog<\/h4>\n
\n
\n PDF Pages<\/th>\n PDF Title<\/th>\n<\/tr>\n \n 2<\/td>\n undefined <\/td>\n<\/tr>\n \n 10<\/td>\n 1 Scope
2 Normative references
3 Terms and definitions <\/td>\n<\/tr>\n\n 13<\/td>\n 4 Abbreviations <\/td>\n<\/tr>\n \n 14<\/td>\n 5 Conformance
5.1 Introduction
5.2 IPS Conformance Detail <\/td>\n<\/tr>\n\n 17<\/td>\n 6 Definition and Descriptors for the IPS Data Set
6.1 International patient summary data set
6.2 IPS Terms and Descriptors <\/td>\n<\/tr>\n\n 19<\/td>\n 6.3 Patterns within the IPS Data Set
6.3.1 General <\/td>\n<\/tr>\n\n 20<\/td>\n 6.3.2 Label Concept
6.3.3 List <\/td>\n<\/tr>\n\n 21<\/td>\n 6.3.4 Reference
6.3.5 Person Name
6.3.6 Coded Element
6.3.7 Date Time <\/td>\n<\/tr>\n\n 22<\/td>\n 6.3.8 Identifier
6.3.9 Address
6.3.10 Telecom
6.3.11 Organization Name <\/td>\n<\/tr>\n\n 23<\/td>\n 6.3.12 Text
6.3.13 Any
6.3.14 Range
6.3.15 Quantity <\/td>\n<\/tr>\n\n 24<\/td>\n 6.3.16 Period
6.3.17 General Time Specification
6.3.18 Healthcare Provider <\/td>\n<\/tr>\n\n 25<\/td>\n 6.3.19 String
6.3.20 Ratio
6.4 Model Extensibility <\/td>\n<\/tr>\n\n 26<\/td>\n 7 Definition of the IPS Document or IPS
7.1 Overview Description: THE IPS DOCUMENT <\/td>\n<\/tr>\n\n 27<\/td>\n 7.2 Detailed Description: THE IPS DOCUMENT <\/td>\n<\/tr>\n \n 30<\/td>\n 8 Definition for IPS Attribute Collection: PATIENT ATTRIBUTES
8.1 Overview Description: PATIENT ATTRIBUTES
8.2 Detailed Description: PATIENT ATTRIBUTES <\/td>\n<\/tr>\n\n 32<\/td>\n 9 Definition for IPS Attribute Collection: PATIENT\u2019S ADDRESS BOOK
9.1 Overview Description for PATIENT\u2019S ADDRESS BOOK <\/td>\n<\/tr>\n\n 33<\/td>\n 9.2 Detailed Description for PATIENT\u2019S ADDRESS BOOK <\/td>\n<\/tr>\n \n 34<\/td>\n 10 Definition for IPS Section: ADVANCE DIRECTIVES
10.1 Overview Description for ADVANCE DIRECTIVES
10.2 Detailed Description for ADVANCE DIRECTIVES <\/td>\n<\/tr>\n\n 36<\/td>\n 11 Definition for IPS Section: ALLERGIES and INTOLERANCES
11.1 Overview Description for ALLERGIES and INTOLERANCES <\/td>\n<\/tr>\n\n 37<\/td>\n 11.2 Detailed Description for ALLERGIES and INTOLERANCES <\/td>\n<\/tr>\n \n 40<\/td>\n 12 Definition for IPS Section: FUNCTIONAL STATUS
12.1 Overview Description for FUNCTIONAL STATUS <\/td>\n<\/tr>\n\n 41<\/td>\n 12.2 Detailed Description for FUNCTIONAL STATUS <\/td>\n<\/tr>\n \n 42<\/td>\n 13 Definition for IPS Section: HISTORY OF PAST PROBLEMS
13.1 Overview Description for HISTORY OF PAST PROBLEMS <\/td>\n<\/tr>\n\n 43<\/td>\n 13.2 Detailed Description for HISTORY OF PAST PROBLEMS <\/td>\n<\/tr>\n \n 44<\/td>\n 14 Definition for IPS Section: HISTORY OF PREGNANCY
14.1 Overview Description for HISTORY OF PREGNANCY <\/td>\n<\/tr>\n\n 45<\/td>\n 14.2 Detailed Description for HISTORY OF PREGNANCY <\/td>\n<\/tr>\n \n 47<\/td>\n 15 Definition for IPS Section: HISTORY OF PROCEDURES
15.1 Overview Description for HISTORY OF PROCEDURES <\/td>\n<\/tr>\n\n 48<\/td>\n 15.2 Detailed Description for HISTORY OF PROCEDURES <\/td>\n<\/tr>\n \n 49<\/td>\n 16 Definition for IPS Section: IMMUNIZATIONS
16.1 Overview Description for IMMUNIZATIONS
16.2 Detailed Description for IMMUNIZATIONS <\/td>\n<\/tr>\n\n 51<\/td>\n 17 Definition for IPS Section: MEDICAL DEVICES
17.1 Overview Description for MEDICAL DEVICES
17.2 Detailed Description for MEDICAL DEVICES <\/td>\n<\/tr>\n\n 52<\/td>\n 18 Definition for IPS Section: MEDICATION SUMMARY
18.1 Overview Description for MEDICATION SUMMARY <\/td>\n<\/tr>\n\n 53<\/td>\n 18.2 The IPS Medication Summary and IDMP <\/td>\n<\/tr>\n \n 54<\/td>\n 18.3 Detailed Description for MEDICATION SUMMARY <\/td>\n<\/tr>\n \n 57<\/td>\n 19 Definition for IPS Section: PLAN OF CARE
19.1 Overview Description for PLAN OF CARE
19.2 Detailed Description for PLAN OF CARE <\/td>\n<\/tr>\n\n 59<\/td>\n 20 Definition for IPS Section: PROBLEMS
20.1 Overview Description for PROBLEMS
20.2 Detailed Description for PROBLEMS <\/td>\n<\/tr>\n\n 61<\/td>\n 21 Definition for IPS Section: Results
21.1 Overview Description for RESULTS
21.2 Detailed Description for RESULTS <\/td>\n<\/tr>\n\n 63<\/td>\n 22 Definition for IPS Section: SOCIAL HISTORY
22.1 Overview Description for SOCIAL HISTORY
22.2 Detailed Description for SOCIAL HISTORY <\/td>\n<\/tr>\n\n 65<\/td>\n 23 Definition for IPS Section: Vital Signs
23.1 Overview Description for VITAL SIGNS
23.2 Detailed Description for VITAL SIGNS <\/td>\n<\/tr>\n\n 67<\/td>\n 24 Definition for IPS Attribute Collection: Cross Border
24.1 Overview Description for CROSS BORDER
24.2 Detailed Description for CROSS BORDER <\/td>\n<\/tr>\n\n 68<\/td>\n 25 Definition for IPS Attribute Collection: Provenance Metadata
25.1 Overview Description for PROVENANCE <\/td>\n<\/tr>\n\n 69<\/td>\n 25.2 Detailed Description for PROVENANCE <\/td>\n<\/tr>\n \n 71<\/td>\n Annex A (informative)The first IPS Scenario focussed on \u2018unscheduled, cross-border care\u2019
A.1 Introduction <\/td>\n<\/tr>\n\n 72<\/td>\n A.2 Commentary on the first IPS Scenario <\/td>\n<\/tr>\n \n 74<\/td>\n A.3 Governance of the IPS Data Set
A.3.1 General
A.3.2 Clinical and Information Governance <\/td>\n<\/tr>\n\n 75<\/td>\n A.4 IPS Independence and Dependence <\/td>\n<\/tr>\n \n 79<\/td>\n Annex B (informative)Explicit Trace between eHN Guideline Version 2
B.1 General
B.2 The eHN Guideline and this IPS standard <\/td>\n<\/tr>\n\n 81<\/td>\n B.3 The Rationale for the IPS Naming <\/td>\n<\/tr>\n \n 82<\/td>\n B.4 Identifiers in eHN Guideline <\/td>\n<\/tr>\n \n 83<\/td>\n Annex C (informative)The eHN Guideline, the JIC PS Standards Set, and IPS <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" \n\n
\n Published By<\/td>\n Publication Date<\/td>\n Number of Pages<\/td>\n<\/tr>\n \n BSI<\/b><\/a><\/td>\n 2019<\/td>\n 86<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"featured_media":350350,"template":"","meta":{"rank_math_lock_modified_date":false,"ep_exclude_from_search":false},"product_cat":[704,2641],"product_tag":[],"class_list":{"0":"post-350345","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-35-240-80","7":"product_cat-bsi","9":"first","10":"instock","11":"sold-individually","12":"shipping-taxable","13":"purchasable","14":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/pdfstandards.shop\/wp-json\/wp\/v2\/product\/350345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pdfstandards.shop\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/pdfstandards.shop\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pdfstandards.shop\/wp-json\/wp\/v2\/media\/350350"}],"wp:attachment":[{"href":"https:\/\/pdfstandards.shop\/wp-json\/wp\/v2\/media?parent=350345"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/pdfstandards.shop\/wp-json\/wp\/v2\/product_cat?post=350345"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/pdfstandards.shop\/wp-json\/wp\/v2\/product_tag?post=350345"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}